Generex’s diabetic drug candidate given FDA approval for experimental use
스크롤 이동 상태바
Generex’s diabetic drug candidate given FDA approval for experimental use
기자명
메디칼라이터팀
입력 2009.09.13 00:00
수정 2009.09.13 10:28
댓글 0
The FDA has approved Generex Biotechnology Corp.’s drug candidate Generex Oral-lyn for experimental use in diabetic patients with dangerous illnesses who don"t have a satisfactory treatment. In order for such drugs to be given experimental approval they must demonstrate a prospect of efficacy and this drug treats diabetes by being delivered through the lining of the mouth.